Clinical trials

Browse a list of current, upcoming and previous clinical trials by condition conducted by research groups across the institute.

Current clinical trials

FURGGHORN (Wet AMD) - HREC/95605/SVHM-2023-367480
GALE (Extension of OAKS) - HREC/77051/SVHM-2021-273676
KIRIN (Wet AMD) - HREC/103832/SVHM-2023-400811
PHOENIX (Dry AMD) - HREC/99641/SVHM-2023-378051
PORTAL (Wet AMD) - HREC/70305/SVHM-2021-264245
VELODROME (Wet AMD) - HREC/69746/2020-001313-20
BENOBIO (Wet AMD) - HREC 2024/ETH01779
ARCHER II (Dry AMD) -SVHM HREC/230/24
CONSTANCE (Wet AMD) -SVHM HREC 310/24

INSITE - HREC/94784/SVHM-2023-358921
RADAR - HREC/13/SAC/92
KIRIN (DME) - HREC/103584/SVHM-2023
VANTAGE – HREC 2024/PID00308
BRUNELLO – SVHM HREC 250/24

Achromatopsia natural history study
GUCY2D related cone dystrophy natural history study
Cone-rod dystrophy or cone dystrophy natural history study
Retinitis Pigmentosa (cone-rod dystrophy) natural history study
- PRPH2 associated retinopathy natural history study
- MERTK associated retinopathy natural history study
- PRPF31 associated retinopathy natural history study
- KCNV2 retinopathy natural history study
- IMPDH1 associated retinopathy natural history study

EPIC Vision Study
Mobility Assessment in Inherited Retinal Diseases using a virtual reality (VR) system - HREC/13962/SESLHD-HREC2020

Stargardt Disease study
Stargardt natural history study
Stargardt (ABCA4) natural history study
Best disease natural history study

MacTel Project - HREC/16/POWH/215

POYANG - HREC/101598/SVHM-2023

Sundew - 2024/ETH00413

SatraGO1 – HREC/97790/SVHM-2023
Immunovant-GO2 - HREC 2024/PID00065

Longbridge – Bellberry 2023/ETH00089

SRI - HREC/18/POWH/562

Usher syndrome trial - HREC/57664/SVHM-2019

ADVISE – HREC/14225/RVEE HREC-2019
SANDCAT – HREC/90343/SVHM-2022

PRISM HREC: 2024/ETH00116

Completed clinical trials

HAWK (Wet AMD) - HREC/15/RPAH/167
RIVAL (Wet AMD) - HREC/13/SHA/46
FILLY (Dry AMD) - HREC/15/RPAH/394
CHROMA (Dry AMD) - HREC/14/RPAH/287
OMASPECT (Dry AMD) - HREC/16/POWH/543
SEQUOIA (Wet AMD) - HREC/15/RPAH/347
ARIES (Wet AMD) - HREC/15/RPAH/387
Talon (Wet AMD) - HREC/53858/SVHM-2019
PANDA (Wet AMD) - HREC/18/SVHM/251
LUCERNE (Wet AMD) - HREC/49517/SVHM-2019
OAKS (Dry AMD) - HREC/18/SVHM/252
MyLight (Wet AMD) - HREC/70671/SVHM-2021-263810
Talon EXTN (Wet AMD) - HREC/67626/SVHM-2020-232811
HORIZON (Dry AMD) - SVHM HREC 294/20
AVONELLE-X (Extension of Lucerne) - HREC/72069/SVHM-2020-244368
Archer Study (Dry AMD) - CALHN HREC 2021/HRE00112
IONIS (Dry AMD) - HREC/50571/SVHM-2018
OTX-TKI (Wet AMD) - HREC/52072/SVHM-2019
PULSAR (Wet AMD) - HREC/63698/SVHM-2020-213156

COMINO (CRVO) - HREC/65387/SVHM-2020-219227
SAPPHIRE (RVO) - HREC/17/POWH/178
TOPAZ (RVO) - HREC/18/MH/103
RAVEN (CRVO) - HREC/51264/SVHM-2019
RIPPLE (RVO) - HREC/67565/SVHM-2020-226369
BALATON (BRVO) - HREC/65076/SVHM-2020-230166
NIRVO (RVO) - HREC/61973/SVHM-2020
QUASAR - HREC/97356/SVHM-2023-367440

AUSSIEDEX - HREC/16/RAH/250
SwitchDMO Study - HREC/12/RPAH/547
Genetic study of Diabetic Retinopathy - SESLHD HREC 08/213
NIRD - HREC/14/RPAH/205
Bevordex (DMO) - LNR/17/POWH/619
Ladamo (DMO) - HREC/14/RPAH/204
Kestrel (DMO) - HREC/18/SVHM/149
RHINE (DMO) - HREC/18/SVHM/240
RIPPLE (DMO) - HREC/67565/SVHM-2020-226369
CANBERRA - HREC/68388/SVHM-2020-230633
RHONE-X (Extension of Rhine) - HREC/63535/SVHM-2020

MacTel CNTF2 - HREC/13/RPAH/393
MacTel Bilateral - SCGOPHCG HREC RGS0000004826
RENEXUS - HREC/17/SVHM/192